Enteric-Coated Mycophenolate Sodium

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Prevention of Acute Rejection After Kidney Transplantation

Drug Information

Target Indication

Prevention of Acute Rejection After Kidney Transplantation

Clinical Trial

Last updated: 2/20/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

NVSEF

NOVARTIS AG

Related Pipeline

Hypertension

Multiple Sclerosis

Influenza

Solid Tumors

Breast Cancer